All News #Library
Biotech
HitGen Secures Funding for Underserved Therapeutics
20 Nov 2025 //
PR NEWSWIRE
BioAge & HitGen Begin Phase 1 Study of BGE-102, NLRP3 Inhibitor
15 Sep 2025 //
PR NEWSWIRE
HitGen Launches OpenDEL™ 5.0 for Enhanced Research Technology
27 Aug 2025 //
PR NEWSWIRE
Bridge Biotherapeutics And HitGen Partner On Cancer Therapeutics
22 Aug 2024 //
PR NEWSWIRE
SGC and HitGen Announce Research Collaboration
28 Sep 2023 //
PR NEWSWIRE
HitGen Announces Drug Discovery Agreement with ARase Therapeutics
18 May 2023 //
PR NEWSWIRE

Market Place
Sourcing Support